Fiche centre
Investigational Site Number : 5780001
Oslo — Norway
Essais liés2clinical trials
VilleOslolocalisation
PaysNorwaylocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT04401020
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| SAR442257 | Cancer | Phase 1 | NCT04401020 | First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL | TERMINATED |
| Tolebrutinib | SEP | Phase 3 | NCT06372145 | A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis. | ACTIVE_NOT_RECRUITING |